Cause of death, by non-communicable diseases, ages 5-14, male in Egypt
Egypt: Cause of death, by non-communicable diseases, ages 5-14, male was 43.6% in 2021. ▲ Rising
Cause of death, by non-communicable diseases, ages 5-14, male in Egypt, 2000–2021
Source: Global Health Estimates, World Health Organization (WHO). Measured in % of total male deaths ages 5-14.
Analysis
The most recent figure for cause of death, by non-communicable diseases, ages 5-14, male in Egypt is 43.6%, measured in 2021.
Compared with earlier readings it is down 5.0% on the previous year and down 2.0% over ten years.
Over the whole period, cause of death, by non-communicable diseases, ages 5-14, male in Egypt peaked at 46.9% in 2019 and was at its lowest, 42.3%, in 2000.
That places Egypt 63rd out of 185 countries with data for 2021, putting it in the middle of the range.
Cause of death, by non-communicable diseases, ages 5-14, male in Egypt, year by year
| Year | % of total male deaths ages 5-14 | Change |
|---|---|---|
| 2000 | 42.3% | — |
| 2010 | 44.5% | +5.2% |
| 2015 | 45.7% | +2.6% |
| 2019 | 46.9% | +2.8% |
| 2020 | 45.9% | -2.2% |
| 2021 | 43.6% | -5.0% |
Egypt compared with similar countries
- Egypt's 43.6% is above the median for lower middle income countries, which is 23.6%, 1.8× the median. (47 countries reporting)
- Egypt's 43.6% is above the median for Middle East, North Africa, Afghanistan & Pakistan, which is 39.3%, 1.1× the median. (23 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 42.3% | 42.3% | 42.3% | 1 |
| 2010s | 45.7% | 44.5% | 46.9% | 3 |
| 2020s | 44.8% | 43.6% | 45.9% | 2 |
Countries ranked near Egypt
More health data for Egypt
- Un projection of annual infant deaths, annual growth rate -1.46 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7884 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 946 deaths per 1,000 people (2090)
- Number of infants who die before age 1 7,225 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate 0.3993 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0487 units per person (2025)
- Population ages 00-04, male, annual growth rate 0.4524 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is cause of death, by non-communicable diseases, ages 5-14, male in Egypt?
- Cause of death, by non-communicable diseases, ages 5-14, male in Egypt was 43.6% in 2021, according to Global Health Estimates, World Health Organization (WHO).
- What is the highest cause of death, by non-communicable diseases, ages 5-14, male recorded in Egypt?
- The highest recorded value was 46.9% in 2019.
- What is the lowest cause of death, by non-communicable diseases, ages 5-14, male recorded in Egypt?
- The lowest recorded value was 42.3% in 2000.
- How does Egypt rank for cause of death, by non-communicable diseases, ages 5-14, male?
- Egypt ranks 63rd out of 185 countries with data for 2021.
- Is cause of death, by non-communicable diseases, ages 5-14, male rising or falling in Egypt?
- Over the last ten years it is down 2.0%. The long-run trend across the full record is rising.
- Where does this Egypt data come from?
- The figures come from Global Health Estimates, World Health Organization (WHO), published as part of Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.